Assessment of cervical and breast cancer screening in Latin America and Caribbean: CanScreen5/CELAC project

Long-term breast cancer risk after benign breast disease in population-based screening

Individualised breast cancer risk assessment model for BreastScreen Norway

Trials in LMIC and HIC – are the standards applicable globally ?

Defining value based care for LMICs

Cancer survivors' stories: An African perspective

ESMO 2022: Highlights, commentary and analysis

Sotorasib shows superior PFS and ORR compared to docetaxel for NSCLC

ESMO 2022: Renal roundup

ESMO 2022: Breast cancer highlights

Cabozantinib in combination w/ nivolumab and ipilimumab of IMDC intermediate or poor risk significantly improved PFS vs PBO

Emerging systemic therapies in rare urothelial cancer variants